HCW BIOLOGICS INC
HCWB · NASDAQ
Updated at 2026-10-14 09:34:49
- Today's High
- $1.45
- Today’s Low
- $1.25
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.56
- Previous Close
- $1.48
- Volume
- 42.97K
- Market Cap
- $3.3M
- P/E Ratio
- --
- EPS
- $-10.91
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 2929 NORTH COMMERCE PARKWAY, MIRAMAR, FL, UNITED STATES, 33025
- Country
- US
- Listing Date
- 2021-07-20
- Fiscal Year End
- December
- Shares Outstanding
- 1.6M
- CIK
- 0001828673
- Website
- hcwbiologics.com
HCW Biologics Inc is a forward-thinking biotechnology company focused on pioneering immunotherapies and vaccine technologies to tackle pressing health issues such as cancer and infectious diseases. Utilizing its proprietary platforms to amplify immune responses, HCW Biologics is actively expanding a promising pipeline of clinical candidates poised to make significant impacts in patient care. With a keen commitment to strategic partnerships and addressing urgent medical needs, the company aims to establish itself as a competitive force in the biotechnology landscape, presenting compelling investment opportunities that align with the evolving dynamics of the healthcare sector.
Financial Metrics
Revenue
2026-06-30
$135.56K
2026-03-31
$6.54M
2025-12-31
$27.01K
2025-09-30
$15.6K
Operating Expenses
2026-06-30
$3.07M
2026-03-31
$3.28M
2025-12-31
$2.95M
2025-09-30
$3.27M
Net Income
2026-06-30
-$5.21M
2026-03-31
$4.13M
2025-12-31
$719.23K
2025-09-30
-$4.55M
Net Profit Margin
2026-06-30
-3.84K%
2026-03-31
63.16%
2025-12-31
2.66K%
2025-09-30
-29.18K%
Earnings Per Share
2026-06-30
$-10.10
2026-03-31
$2.22
2025-12-31
$-6.12
2025-09-30
$-12.12
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$4.97M
2026-03-31
$3.83M
2025-12-31
$1.1M
2025-09-30
-$4.23M
Effective Tax Rate
2026-06-30
-195.28%
2026-03-31
-8.68%
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $135.56K | $6.54M | $27.01K | $15.6K |
| Operating Expenses | $3.07M | $3.28M | $2.95M | $3.27M |
| Net Income | -$5.21M | $4.13M | $719.23K | -$4.55M |
| Net Profit Margin | -3.84K% | 63.16% | 2.66K% | -29.18K% |
| Earnings Per Share | $-10.10 | $2.22 | $-6.12 | $-12.12 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$4.97M | $3.83M | $1.1M | -$4.23M |
| Effective Tax Rate | -195.28% | -8.68% | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.